Table 4.
Remission and response rates at 2 weeks, 4 weeks and 4 months in each group
| tDCS + rTMS Group (n = 56) | sham tDCS + rTMS Group (n = 50) | tDCS + sham rTMS Group (n = 51) | χ2 | p value | |
|---|---|---|---|---|---|
| Remission %(n) | |||||
| 2 weeks | 12.50% (7) | 8.00% (4) | 3.92% (2) | 5.378 | 0.068 |
| 4 weeks | 46.43% (26) | 30.00% (15) | 21.57% (11) | 13.579 | 0.001 |
| 4 months | 19.64% (11) | 14.00% (7) | 9.80% (5) | 4.048 | 0.132 |
| Response %(n) | |||||
| 2 weeks | 53.57% (30) | 34.00% (17) | 21.57% (11) | 22.507 | < 0.001 |
| 4 weeks | 64.29% (36) | 44.00% (22) | 27.45% (14) | 27.717 | < 0.001 |
| 4 months | 42.86% (24) | 36.00% (18) | 23.53% (12) | 8.191 | 0.017 |
Response was defined as the percentage of those with at least a 50% reduction in the PSQI total score from baseline. Remission was defined as a PSQI total score < 5. PSQI Pittsburgh Sleep Quality Index, χ2 and p for group effects. Significant results are highlighted (p < 0.05) in bold